Non invasive genetic testing > non invasive dna testing > Ninalia NIPT

NIPT by Biomnis The new prenatal trisomy screening test based on maternal blood sample

Trisomy 13

Download the brochure

Non invasive genetic testing

Non-invasive genetic testing 

Non-Invasive Genetic Testing Can Offer Peace Of Mind, Early On

Learning that you are expecting a baby is one of life's most joyous momentsâ€but it can also come attached with some anxiety when you learn about common pregnancy risks and abnormalities. Expectant parents routinely undergo fetal diagnosis tests to rule out chromosomal disorders including Down Syndrome. As an alternative to invasive and potentially risky procedures including amniocentesis for Patau Syndrome screening, Eurofins Biomnis offers non-invasive genetic testing with fast and accurate results. The test draws analysis from a maternal blood sample, and can be prescribed starting at only 10 weeks of pregnancy. By opting for this non-invasive genetic testing option, risks of chromosomal defects can be screened with remarkable accuracy.

Although most expectant parents are aware of risks for fetal genetic defects, and wonder whether disorders such as Edwards Syndrome can be detected, many people are unaware that non-invasive genetic testing during pregnancy is an option. However, effective and entirely safe non-invasive testing methods are now readily available. Safe, reliable, and rapid, the test can be obtained starting in only the tenth week of pregnancy. It simultaneously detects risks for trisomies 13, 18 and 21â€offering peace of mind from earlier on. Explore the website to learn more about why non-invasive genetic testing during pregnancy may be the right option for you.

When it comes to prenatal screening and diagnosis, it can be easy to assume that non-invasive DNA testing must be at least as complicated as traditional, invasive procedures such as amniocentesis. In reality, the innovative testing kit developed by Eurofins Biomnis is remarkably simple to prescribe and administer. It can be prescribed by your regular healthcare provider, and you can have the blood test taken at your physician's office or at aEurofins Biomnis partner laboratory. With results of the blood test available in around 7 working days, NIPT by EurofinsBiomnis is a remarkably easy and painless form of non-invasive DNA testing. It has been found to reduce unnecessary invasive sampling by up to 95%.

Advantages of NIPT by Biomnis

> 99 % Detection rateof NIPT test 1 Single blood sample 10 Available from week 10of amenorrhoea 7 Results availablewithin 7 working days 95 % Can minimize unnecessary invasive sampling by 95%